Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

Murine embryonic fibroblasts lacking TC-PTP display delayed G1 phase through defective NF-κB activation

Abstract

Previous results suggested a potential role for T-cell protein tyrosine phosphatase (TC-PTP) in cell proliferation. However, no conclusive data has supported such a function in the modulation of this process. In order to clarify this issue, we isolated TC-PTP−/− murine embryonic fibroblasts (MEFs) as well as cell lines to characterize the role of TC-PTP in the control of cell proliferation and cell cycle. Both TC-PTP−/− primary MEFs and cell lines proliferate slower than TC-PTP+/+ cells. We also demonstrated that TC-PTP−/− cells have a slow progression through the G1 phase of the cell cycle. Further characterization of the G1 defect indicates that the kinetics of cyclin D1 induction was delayed and that p27KIP1 remains at higher levels for an extended period of time. Moreover, cells lacking TC-PTP showed a delayed activation of CDK2. This slow progression through the early G1-phase resulted in decreased phosphorylation of the RB protein and subsequent delay into the S phase transition. In contrast, no further defects were detected in other phases of the cell cycle. Survey of the potential signaling pathways leading to this delayed cyclin D1 expression indicated that NF-κB activation was compromised and that IKKβ activity was also reduced following PDGF stimulation. Reintroduction of wild-type TC-PTP into the TC-PTP−/− cells rescued the defective proliferation, cyclin D1 expression, NF-κB activation as well as IκB phosphorylation. Together, these results confirm that TC-PTP plays a positive role in the progression of early G1 phase of the cell cycle through the NF-κB pathway.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7

Similar content being viewed by others

References

  • Bargou RC, Emmerich F, Krappmann D, Bommert K, Mapara MY, Arnold W, Roger HD, Grinstein E, Scheidereit C . 1997 J. Clin. Invest. 100: 405–455

  • Cheng M, Sexl V, Sherr CJ, Roussel MF . 1998 Proc. Natl. Acad. Sci. USA 95: 1091–1096

  • Cheng M, Olivier P, Diehl JA, Fero M, Roussel MF, Roberts JM, Sherr CJ . 1999 EMBO J. 18: 1571–1583

  • Cool D, Tonks N, Charbonneau H, Walsh K, Fischer E, Krebs E . 1989 Proc. Natl. Acad. Sci. USA 86: 5257–5261

  • Diehl JA, Cheng M, Roussel MF, Sherr CJ . 1998 Genes Dev. 12: 3499–3511

  • Fagan R, Flint K, Jones N . 1994 Cell 78: 799–811

  • Ferreira V, Sidenius N, Tarantino N, Hubert P, Chatenoud L, Blasi F, Korner M . 1999 J. Immunol. 162: 6442–6450

  • Gille H, Downward J . 1999 J. Biol. Chem. 274: 22033–22040

  • Grumont RJ, Rourke IJ, O'Reilly LA, Strasser A, Miyake K, Sha W, Gerondakis S . 1998 J. Exp. Med. 187: 663–674

  • Guttridge DC, Albanese C, Reuther JY, Pestell RG, Baldwin ASJ . 1999 Mol. Cell Biol. 19: 5785–5799

  • Habib A, Chatterjee S, Park S, Ratan R, Lefebvre S, Vartanian T . 2001 J. Biol Chem. 276: 8865–8874

  • Hengst L, Reed SI . 1996 Science 271: 1861–1864

  • Hinz M, Krappmann D, Eichten A, Heder A, Scheidereit C, Strauss M . 1999 Mol. Cell Biol. 19: 2690–2698

  • Hsiao K, McMahon S, Farnham P . 1994 Genes Dev. 8: 1526–1537

  • Ibarra-Sánchez M, Simoncic P, Nestel F, Lapp W, Tremblay ML . 2000 Semm. Immunol. 12: 379–386

  • Johnson D, Ohtani K, Nevins J . 1994 Genes Dev. 8: 1514–1525

  • Kerkhoff E, Rapp UR . 1997 Mol. Cell Biol. 17: 2576–2586

  • Kerkhoff E, Rapp UR . 1998 Oncogene 17: 1457–1462

  • Liou H-CJZ, Tumang J, Andjelic S, Smith KA . 1999 Int. Immunol. 11: 361–371

  • Llyod AC, Obermuller F, Staddon SCB, McMahon M, Land H . 1997 Genes Dev. 11: 663–677

  • Lorenzen J, Dabaday C, Fischer E . 1995 J. Biol Chem. 14: 631–643

  • Mosinger B, Tillmann U, Westphal H, Tremblay ML . 1992 Proc. Natl. Acad. Sci. USA 89: 499–503

  • Mosmann T . 1983 J. Immunol. Methods 62: 55–63

  • Muise-Helmericks RC, Grimes HL, Bellacosa A, Malstrom SE, Tsichlis PN, Rosen N . 1998 J. Biol. Chem. 273: 29864–29872

  • Nambirajan S, Radha V, Kamatkar S, Swarup G . 2000 J Biosci. 25: 33–40

  • Nambirajan S, Reddy R, Swarup G . 1995 J Biosci. 20: 461–471

  • Neuman E, Flemington E, Sellers W, Kaelin WJ . 1994 Mol. Cell Biol. 14: 6607–6615

  • Nourse J, Firpo E, Flanagan WM, Coats S, Polyak K, Lee MH, Massague J, Crabtree GR, Roberts JM . 1994 Nature 372: 570–573

  • Pagano M, Tam SW, Theodoras AM, Beer-Romero P, Del Sal G, Chau V, Yew PR, Draetta GF, Rolfe M . 1995 Science 269: 682–685

  • Radha V, Nambirajan S, Swarup G . 1997 FEBS lett. 409: 33–36

  • Serrano M, Lin AW, McCurrach ME, Beach D, Lowe SW . 1997 Cell 88: 593–602

  • Sewing A, Wiseman B, Llyod AC, Land H . 1997 Mol. Cell. Biol. 17: 5588–5597

  • Sha WC, Liou H-C, Toumanen EI . 1995 Cell 80: 321–330

  • Sheaff RJ, Groudine M, Gordon M, Roberts JM, Clurman BE . 1997 Genes Dev. 11: 1464–1478

  • Sherr CJ . 1994 Cell 79: 551–555

  • Sherr CJ . 1996 Science 274: 1672–1677

  • Sherr C, Roberts J . 1999 Genes Dev. 13: 1501–1512

  • Snapper CM, Zelazowski P, Rosas FR, Kehry MR, Tian M, Baltimore D, Sha WC . 1996 J. Immunol. 156: 183–191

  • Tiganis T, Bennett A, Ravichandran K, Tonks N . 1998 Mol. Cell Biol. 18: 1622–1634

  • Tiganis T, Flint A, Adam S, Tonks N . 1997 J. Biol. Chem. 272: 21548–21557

  • Tillmann U, Wagner J, Boerboom D, Westphal H, Tremblay ML . 1994 Mol. Cell Biol. 14: 3030–3040

  • Tonks N, Neel B . 2001 Curr. Opin. Cell Biol. 13: 182–195

  • Vidal A, Koff A . 2000 Gene 247: 1–15

  • Vlach J, Hennecke S, Amati B . 1997 EMBO J. 16: 5334–5344

  • Woods D, Parry D, Cherwinski H, Bosch E, Lees E, McMahon M . 1997 Mol. Cell Biol. 17: 5598–5611

  • You M, Flick L, Yu D, Feng G . 2001 J. Exp. Med. 193: 101–110

  • You-Ten K, Muise E, Itie A, Michaliszyn E, Wagner J, Jothy S, Lapp WS, Tremblay ML . 1997 J. Exp. Med. 186: 683–693

Download references

Acknowledgements

We are grateful to Phil E Branton for the generous gift of anti-RB antibody. We thank Alan Cheng, Jean François Côté, Mounib Elchebly, Pankaj Tailor and François Blondeau for helpful discussion and critical reading of the manuscript. We acknowledge the contribution of Eva Michaliszyn, Jacklin Quinlan and Ailsa Lee Loy for their excellent technical work. We also thank Louie Lamorte and Morag Park for their suggestions and help in the generation of the TC-PTP retrovirus expression vector. María de Jesús Ibarra-Sánchez received studentships from the Canderel Foundation, the Alexander McFee Memorial Fellowship and the Internal Studentship of Faculty of Medicine at McGill University. ML Tremblay is a Scientist of Canadian Institutes for Health Research (CIHR). This work was supported by an operating grant to ML Tremblay from the National Cancer Institute (NCI) of Canada.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Michel L Tremblay.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ibarra-Sánchez, M., Wagner, J., Ong, MT. et al. Murine embryonic fibroblasts lacking TC-PTP display delayed G1 phase through defective NF-κB activation. Oncogene 20, 4728–4739 (2001). https://doi.org/10.1038/sj.onc.1204648

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1204648

Keywords

This article is cited by

Search

Quick links